ArticleMolecular biotechnology2026
Green Synthesis of Copper, Iron and Silver Nanoparticles from Origanum vulgare L. subsp. vulgare; Characterization, In Vitro Enzyme Inhibition, Antimicrobial Activities and In Silico Molecular Docking Studies.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green Synthesis of Silver Nanoparticles from Cotoneaster lacteus: Experimental Characterization and Mechanistic Insights from Biological Assays, DFT and Molecular Docking Studies.Applied biochemistry and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study revealed the characteristics of the ethanol extract of Origanum vulgare L. subsp. vulgare, copper, iron, and silver nanoparticles (CuNPs, FeNPs, AgNPs) were synthesized with the extracts for the first time. The NPs were characterized using field emission scanning electron microscopes (FE-SEM), field emission scanning electron microscope-energy-dispersive X-ray analysis (FESEM-EDX), transmission electron microscopy (TEM), and Fourier transform infrared spectroscopy (FT-IR). UV-Vis spectrophotometry is used for the confirmation of NPs. The extract had bioactive components, including thymol (35.99%) and naringenin (41.02 µg/g). Molecular docking of thymol/naringenin-AgNPs complexes with the PapR7 C-terminus produced MolDock scores of - 122.545 and - 94.929 for naringenin-AgNPs and thymol-AgNPs. AgNPs and CuNPs exhibited potent antibacterial activity against Bacillus cereus, Staphylococcus aureus, and Pseudomonas aeruginosa. AgNPs exhibited protease activity (5 mg/mL), and CuNPs exhibited lipase activity (5 and 10 mg/mL). FeNPs exhibited weak inhibitory properties (IC
Indexed as
Identifiers
41317252What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.